https://pharmadog.xyz/news/646339 pharmadog en 2026-11-06T17:46:16.000Z Democrats’ Midterm Win Promises Medicaid Reversal and ACA Subsidy Restoration for Hospitals https://pharmadog.xyz/news/646340 pharmadog en 2026-11-06T17:02:18.000Z Podcast examines Democrats' midterm win and concerns over a costly, questionable fertility genetic procedure https://pharmadog.xyz/news/646295 pharmadog en 2026-11-06T17:00:22.000Z Immunocore reports early data showing 70% two-year survival with brenetafusp/Kimmtrak combo in uveal melanoma https://pharmadog.xyz/news/646127 pharmadog en 2026-11-06T16:53:33.000Z FDA grants accelerated approval to J&J's Rybrevant for recurrent head and neck cancer https://pharmadog.xyz/news/646359 pharmadog en 2026-11-06T16:51:00.000Z Novartis reports nine cancer cases in patients treated with Zolgensma gene therapy https://pharmadog.xyz/news/646171 pharmadog en 2026-11-06T16:43:49.000Z MetaVia appoints Sarah Browne as chief medical officer https://pharmadog.xyz/news/646151 pharmadog en 2026-11-06T16:43:26.000Z Moderna reports 29% revenue rise as COVID vaccine sales stay steady amid global uptake https://pharmadog.xyz/news/646172 pharmadog en 2026-11-06T16:14:40.000Z New evidence links AAV gene therapies to tumor risk, raising safety concerns https://pharmadog.xyz/news/646128 pharmadog en 2026-11-06T16:08:42.000Z Amgen's Repatha shows reduced heart attack risk while Satellos alters Duchenne trial endpoint https://pharmadog.xyz/news/134233 pharmadog en 2026-11-06T15:46:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/645984 pharmadog en 2026-11-06T15:25:02.000Z Forge Biologics VP sees AI and Ohio talent driving next wave of gene therapy manufacturing https://pharmadog.xyz/news/646003 pharmadog en 2026-11-06T15:14:53.000Z Amgen’s Repatha linked to fewer heart attacks while Novartis reports seven new tumor cases in Zolgensma patients https://pharmadog.xyz/news/645727 pharmadog en 2026-11-06T14:59:42.000Z Study finds ritual cannabis use in 2,800-year-old Siberian tomb https://pharmadog.xyz/news/645728 pharmadog en 2026-11-06T14:41:03.000Z Novartis reports seven tumor cases in children treated with Zolgensma https://pharmadog.xyz/news/645707 pharmadog en 2026-11-06T14:21:05.000Z Agios cuts over 35% of R&D staff as FDA decision on sickle cell drug is delayed https://pharmadog.xyz/news/645708 pharmadog en 2026-11-06T14:19:01.000Z Sarepta CEO Sees Path to Stronger DMD Trials Amid 2025 Elevidys Setbacks https://pharmadog.xyz/news/645683 pharmadog en 2026-11-06T14:10:47.000Z Sarepta halts enrollment in confirmatory Phase 3 trial of Elevidys gene therapy for Duchenne muscular dystrophy https://pharmadog.xyz/news/645747 pharmadog en 2026-11-06T13:13:00.000Z Eli Lilly partners with Hims & Hers to sell Zepbound and Foundayo via telehealth platform https://pharmadog.xyz/news/645539 pharmadog en 2026-11-06T13:04:52.000Z Verdicts for Summit/Akeso, Capricor, Vertex mark FDA’s stacked November https://pharmadog.xyz/news/645515 pharmadog en 2026-11-06T13:02:48.000Z Moderna posts first profit in two years, driven by Covid-19 vaccine sales, as it refocuses on cancer vaccines https://pharmadog.xyz/news/645371 pharmadog en 2026-11-06T12:35:21.000Z Merck and Moderna report 99% manufacturing success and 42% lower recurrence risk for personalized melanoma vaccine in Phase 3 trial https://pharmadog.xyz/news/645347 pharmadog en 2026-11-06T12:00:44.000Z Novo and Pfizer appoint new CFOs while Alnylam sees departure of its chief commercial officer https://pharmadog.xyz/news/645243 pharmadog en 2026-11-06T12:00:00.000Z Novo Nordisk’s oral Wegovy sales beat forecasts, boosting shares over 5% https://pharmadog.xyz/news/646271 pharmadog en 2026-11-06T10:13:00.000Z Axiom Biosciences pursues Hong Kong IPO and novel stem cell platform amid funding challenges https://pharmadog.xyz/news/646273 pharmadog en 2026-11-06T09:52:00.000Z Moderna pauses norovirus vaccine trial after missing interim analysis https://pharmadog.xyz/news/644888 pharmadog en 2026-11-06T09:30:00.000Z Medical records often miss women's health experiences, limiting AI's potential https://pharmadog.xyz/news/644887 pharmadog en 2026-11-06T09:30:00.000Z Medicare delays controversial remote patient monitoring ban to 2029, opening window for provider pushback https://pharmadog.xyz/news/644889 pharmadog en 2026-11-06T09:30:00.000Z Kratom use rises as health officials warn of addiction risk and push emergency bans https://pharmadog.xyz/news/644890 pharmadog en 2026-11-06T09:30:00.000Z Opinion: STAT+: What it’s like to live with cognitively unimpaired Alzheimer’s disease https://pharmadog.xyz/news/646274 pharmadog en 2026-11-06T04:21:00.000Z Merck ends Sutro partnership on IL-2 agonist MK-1484 amid routine pipeline prioritization https://pharmadog.xyz/news/646275 pharmadog en 2026-11-06T02:36:00.000Z Siemens Healthineers to spin off in‑vitro diagnostics unit as Olyrian Diagnostics, rebranding to Healthineers https://pharmadog.xyz/news/642862 pharmadog en 2026-11-05T22:30:38.000Z FDA grants accelerated approval for Rybrevant Faspro in recurrent/metastatic head and neck cancer https://pharmadog.xyz/news/642655 pharmadog en 2026-11-05T21:36:52.000Z PhRMA spent roughly $59 million on search ads to shape public views on drug pricing https://pharmadog.xyz/news/642675 pharmadog en 2026-11-05T21:06:00.000Z Medicare to slash 340B drug payments and expand site-neutral rules in 2027 https://pharmadog.xyz/news/642443 pharmadog en 2026-11-05T20:52:52.000Z New treatments for preeclampsia move closer to patients https://pharmadog.xyz/news/642487 pharmadog en 2026-11-05T20:49:33.000Z Ballot measures on abortion, marijuana and transgender youth care highlight political divides in 2026 midterms https://pharmadog.xyz/news/642275 pharmadog en 2026-11-05T19:19:22.000Z AAFP chief urges Congress to add oversight to CDC vaccine advisory panel https://pharmadog.xyz/news/642043 pharmadog en 2026-11-05T18:53:34.000Z Novartis reports seven new tumor cases in children treated with Zolgensma gene therapy https://pharmadog.xyz/news/642044 pharmadog en 2026-11-05T18:19:08.000Z MIT defamation verdict awards $6 million to former star scientist, sparking campus debate over harassment claims https://pharmadog.xyz/news/642045 pharmadog en 2026-11-05T18:09:39.000Z Trump administration ends contracts with two No Surprises Act arbitrators over performance failures https://pharmadog.xyz/news/641875 pharmadog en 2026-11-05T18:00:23.000Z MAHA movement faces electoral defeat as its political influence wanes https://pharmadog.xyz/news/641855 pharmadog en 2026-11-05T17:19:07.000Z Novartis reports nine tumor cases in patients treated with Zolgensma gene therapy https://pharmadog.xyz/news/641895 pharmadog en 2026-11-05T17:09:00.000Z J&J and AbbVie present early trispecific antibody data for multiple myeloma at ASH meeting https://pharmadog.xyz/news/641707 pharmadog en 2026-11-05T16:22:53.000Z Sickle cell gene-editing therapy shows signs of revival as developers revisit trial after earlier safety halt https://pharmadog.xyz/news/641727 pharmadog en 2026-11-05T16:21:00.000Z Revolution Medicines reports $198 million Q3 sales for pancreatic cancer drug Rasonque, calling it best oncology launch ever https://pharmadog.xyz/news/641495 pharmadog en 2026-11-05T15:59:19.000Z RevMed stock rises on early Rasonque sales as whistleblower sues Madrigal over MASH safety https://pharmadog.xyz/news/641539 pharmadog en 2026-11-05T15:41:24.000Z Democratic doctors celebrate gains as MAHA’s future remains uncertain after election https://pharmadog.xyz/news/641519 pharmadog en 2026-11-05T15:39:43.000Z RevMed's pancreatic cancer drug Rasonque generates $198M in Q3, far exceeding forecasts https://pharmadog.xyz/news/641496 pharmadog en 2026-11-05T15:27:30.000Z Caldera and Evommune secure China licensing agreements for autoimmune drug assets https://pharmadog.xyz/news/646270 pharmadog en 2026-11-05T15:09:00.000Z Novo names former Galderma exec as new CFO as eight-year finance chief departs; Alnylam and Amgen also seek senior replacements https://pharmadog.xyz/news/641520 pharmadog en 2026-11-05T15:01:20.000Z British biotech T-Therapeutics raises $133 million Series B to advance bispecific T-cell engagers https://pharmadog.xyz/news/641497 pharmadog en 2026-11-05T15:00:22.000Z Merck reports positive mid-stage results for Hanmi-licensed MASH drug https://pharmadog.xyz/news/641371 pharmadog en 2026-11-05T14:49:16.000Z India proposes rule to instantly suspend drug manufacturing licenses that fail government quality tests https://pharmadog.xyz/news/641327 pharmadog en 2026-11-05T14:00:40.000Z Ellipsis Health acquires Kouper Health to expand AI voice call capabilities https://pharmadog.xyz/news/641372 pharmadog en 2026-11-05T14:00:00.000Z STAT+: Beyond statins, one drug lowered heart attack risk by 20% https://pharmadog.xyz/news/641183 pharmadog en 2026-11-05T13:53:16.000Z Evommune pays $30 million upfront to license Hinova’s oral molecular glue degrader for autoimmune pipeline https://pharmadog.xyz/news/641184 pharmadog en 2026-11-05T13:32:52.000Z AstraZeneca reportedly bids $10 billion for metabolic biotech Rhythm Pharmaceuticals https://pharmadog.xyz/news/641203 pharmadog en 2026-11-05T13:04:15.000Z Medicare postpones controversial rule that bars hospitals from using third-party remote patient monitoring services https://pharmadog.xyz/news/641035 pharmadog en 2026-11-05T12:58:19.000Z Democrats’ midterm sweep positions Bernie Sanders to steer Senate health committee, raising hopes for major FDA reforms https://pharmadog.xyz/news/641223 pharmadog en 2026-11-05T12:52:00.000Z T-Therapeutics secures $133 million Series B to advance bispecific cancer and autoimmune drugs https://pharmadog.xyz/news/641036 pharmadog en 2026-11-05T12:33:01.000Z Revolution Medicines' Rasonque generates $198 million in sales within five weeks of U.S. approval https://pharmadog.xyz/news/640847 pharmadog en 2026-11-05T11:42:40.000Z Podcast explores how intratumoral injections may spark systemic cancer immunity https://pharmadog.xyz/news/640759 pharmadog en 2026-11-05T11:30:00.000Z ProMis shares tumble after competitor's Alzheimer trial failure, CEO calls reaction overblown https://pharmadog.xyz/news/641470 pharmadog en 2026-11-05T09:57:00.000Z Rezera targets $181 million IPO to fund phase-3 trial of NLRP3 inhibitor for peripheral artery disease https://pharmadog.xyz/news/641471 pharmadog en 2026-11-05T09:53:00.000Z MetaVia's GLP-1/glucagon agonist cuts liver fat and weight in phase 1, eyes phase 2 in alcohol-related liver disease https://pharmadog.xyz/news/646272 pharmadog en 2026-11-05T09:41:00.000Z Generate Biomedicines CEO touts AI-driven shrinkage of CAR-T cell engines as huge opportunity https://pharmadog.xyz/news/641472 pharmadog en 2026-11-05T09:38:00.000Z AstraZeneca proposes $10 billion purchase of Rhythm Pharmaceuticals, sparking possible bidding war https://pharmadog.xyz/news/640425 pharmadog en 2026-11-05T09:30:00.000Z China clamps down on investigator-initiated biotech trials after patient deaths, halting rare-disease studies https://pharmadog.xyz/news/640426 pharmadog en 2026-11-05T09:30:00.000Z Neurosurgeon reflects on the difference between pain and suffering in chronic back pain patients https://pharmadog.xyz/news/640424 pharmadog en 2026-11-05T09:30:00.000Z Health systems grapple with AI chatbot use, some block tools while others consider in-house solutions https://pharmadog.xyz/news/641302 pharmadog en 2026-11-05T08:41:00.000Z Agios to cut over 202 R&D positions as it awaits FDA decision on sickle cell drug https://pharmadog.xyz/news/640211 pharmadog en 2026-11-05T08:00:50.000Z Alethio Therapeutics raises $90 million Series A to develop antibody for essential thrombocythemia https://pharmadog.xyz/news/640275 pharmadog en 2026-11-05T08:00:00.000Z Alethio Therapeutics secures $90 million to develop treatments for rare blood cancers https://pharmadog.xyz/news/197927 pharmadog en 2026-11-05T07:01:00.000Z BioSpace lists top 12 biopharma employers hiring in July 2026 https://pharmadog.xyz/news/640043 pharmadog en 2026-11-05T07:00:00.000Z T-Therapeutics raises $133 million from Sanofi, J&J, Merck KGaA and Eli Lilly for TCR cancer and autoimmune programs https://pharmadog.xyz/news/639731 pharmadog en 2026-11-05T05:54:00.000Z Madrigal’s 2024 MASH drug sparks new wave of diagnosis and personalized treatment approaches https://pharmadog.xyz/news/641134 pharmadog en 2026-11-05T05:51:00.000Z Vivoryon reclaims Chinese rights to kidney disease drug amid cash crunch https://pharmadog.xyz/news/639732 pharmadog en 2026-11-05T05:01:00.000Z One in Five Biopharma Workers Have Been Laid Off Multiple Times, Survey Shows https://pharmadog.xyz/news/641135 pharmadog en 2026-11-05T04:55:00.000Z Evommune pays $30 million to Hinova for rights to develop oral VAV1 molecular glue degrader EVO570 outside China https://pharmadog.xyz/news/640523 pharmadog en 2026-11-05T03:47:00.000Z Cloudbreak Pharma’s Phase 3 Eye Drop Shows Significant Benefit in Pterygium Trial https://pharmadog.xyz/news/642854 pharmadog en 2026-11-05T00:00:00.000Z MDCG issues guidance on clinical evidence for orphan in-vitro diagnostics https://pharmadog.xyz/news/642853 pharmadog en 2026-11-05T00:00:00.000Z FDA official says midterm elections unlikely to delay user fee reauthorization for FY 2028-2032 https://pharmadog.xyz/news/643465 pharmadog en 2026-11-05T00:00:00.000Z Experts urge streamlined EU AI framework and higher regulatory literacy for healthcare products https://pharmadog.xyz/news/638191 pharmadog en 2026-11-04T21:17:19.000Z Bernie Sanders poised to steer FDA user fee renewal, could push for reforms https://pharmadog.xyz/news/637979 pharmadog en 2026-11-04T20:05:28.000Z Kamau Therapeutics presents first clinical data from its updated sickle-cell gene-editing program https://pharmadog.xyz/news/637855 pharmadog en 2026-11-04T19:40:32.000Z Massachusetts voters reject repeal of recreational cannabis sales, keeping industry open https://pharmadog.xyz/news/637835 pharmadog en 2026-11-04T19:32:28.000Z Boehringer bets big on China, offering $7B biobucks for Sino cancer programs